Abiomed
$381.02
24H
Market Cap
Volume
Supply
Price Chart
About Abiomed - ABMD
Abiomed, Inc. is a medical device company that specializes in developing products aimed at improving circulatory support, particularly through its Impella heart pump technology, which is used in cardiac procedures to help maintain the heart's pumping function.
What are Abiomed's core values and mission statement?
Abiomed, Inc. is dedicated to improving the quality of healthcare by providing patients with innovative medical devices that support or replace failing heart function, aiming to recover hearts and save lives with a focus on patient care and outcomes. Their mission includes a commitment to understanding and serving patient needs, fostering a culture of relentless innovation, and delivering superior value to their customers, employees, and shareholders.
Who founded Abiomed and when?
Abiomed, Inc. was founded by David M. Lederman in 1981.
Who leads Abiomed?
As of the last available information, Michael R. Minogue serves as the Chairman, President, and Chief Executive Officer of Abiomed, Inc.
Where is Abiomed located, and what is its base country?
Abiomed, Inc. is headquartered in Danvers, Massachusetts, United States, which is also its base country.
On which exchanges is Abiomed traded?
Abiomed, Inc. is traded on the NASDAQ stock exchange under the ticker symbol ABMD.
Historical data
Abiomed (ABMD) Price Live Data
The live price of Abiomed (ABMD) is $381.02, with a trading volume of 15,702,662 in the last 24 hours. Wrapstocks updates the ABMD price in real-time. Abiomed is up 0% in the last 24 hours. The company has a live market cap of $17,180,649,472.00 and a supply of 45,091,201 ABMD stocks.
Abiomed (ABMD) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 9 hours and 0 minutes.
